LEADERSHIP

Led with experience, backed by an eye for innovation

Inscripta® is led by an experienced management team and board who have been behind some of the most innovative life science and biotechnology companies in the world. The company is backed by a world class group of institutional investors and venture capital firms.

Inscripta Team

Sri Kosaraju
President and Chief Executive Officer
Richard Fox
Chief Scientist
Ted Tarasow
Chief Technology Officer
Andrew Horwitz
Vice President, Product Development
Caroline Bone
Director, Business Operations
Morgan Xu
Vice President, Legal and IP
Michael Seater
Controller

Inscripta Board

Sri Kosaraju
President and Chief Executive Officer
John Stuelpnagel
Chairman
Kristala Prather
Board of Directors
Bryan Roberts
Board of Directors
Roger Wyse
Board of Directors